Analysts at Noble Capital Markets have repeated their ‘Market Perform' rating on MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) after the company received registration approval for its biofertility product TerraSante in Arizona. The approval allows MustGrow to commence TerraSante sales in the state, which produced $3 billion in total agricultural crop products in 2022.
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has received the Arizona Department of Agriculture registration approval for its mustard plant-based biofertility product TerraSante. TerraSante contains plant proteins and carbohydrates that feed the soil and soil microbes and improve soil health, leading to improved crop nutrient uptake and, in turn, better overall crop performance.
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced it has received registration approval from the Idaho State Department of Agriculture for its mustard-based biofertility product TerraSante. The agriculture biotechnology company said the Idaho organic certification is included under MustGrow's existing Organic OMRI Listed certifications in Oregon and Washington State.
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that it has ramped up its sales and marketing efforts in California for its mustard-derived organic biofertility product TerraSante, which is focused on soil microbiome health, nutrient and water use efficiency and plant yields. The agriculture biotechnology company said it will be attending Strawberry Center Field Day at Cal Poly to promote TerraSante to hundreds of strawberry growers, researchers, and farming industry representatives.
MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has joined an international consortium that is looking for ways to combat the fungal disease currently threatening the banana industry. The company has been accepted as a member of the Global Alliance Against TR4, which brings together food brands such as Chiquita, Dole, Fyffes and Del Monte, with value chain companies, researchers from the likes of Bayer and various universities, trade associations, financial services, the public sector and civil society to defeat the Fusarium wilt TR4 (TR4) fungal disease.